Design, synthesis and characterization of picoline based organoselenium compounds, 1,2-bis(pyridine-2/3/4-yl)methyl diselanes: X-ray crystal structure of 1,2-bis(pyridine-3-yl)methyldiselane

dc.contributor.authorRishu
dc.date.accessioned2020-12-09T09:18:36Z
dc.date.available2020-12-09T09:18:36Z
dc.date.issued2015
dc.descriptionOnly IISERM authors are available in the record.
dc.description.abstractAn efficient synthetic protocol affording symmetrical 1,2-bis(pyridine-2/3/4-yl)methyldiselanes from pyridine-2/3/4-carbaldehyde in high yields at room temperature, without using highly toxic hydrogen selenide, has been developed. The synthesis involves the reductive selenation of pyridine-2/3/4-carbaldehyde with sodium hydrogen selenide, NaHSe in the presence of piperidine hydrochloride followed by NaBH4 reduction under mild conditions. Primary screening of the anti-proliferative activity of the newly synthesized compounds against several mammalian cell lines and pathogenic strains has been carried out. The crystal structure of 1,2-bis(pyridine-3-yl)methyldiselane has been established by X-ray diffraction analysis.en_US
dc.identifier.citationJournal of Organometallic Chemistry, 785 pp. 19-25en_US
dc.identifier.other10.1016/j.jorganchem.2015.02.024
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0022328X15000923
dc.identifier.urihttp://hdl.handle.net/123456789/2900
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.subjectCarbaldehydeen_US
dc.subjectPiperidineen_US
dc.subjectSeleniumen_US
dc.subjectDiselaneen_US
dc.titleDesign, synthesis and characterization of picoline based organoselenium compounds, 1,2-bis(pyridine-2/3/4-yl)methyl diselanes: X-ray crystal structure of 1,2-bis(pyridine-3-yl)methyldiselaneen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Need to add pdf.odt
Size:
8.63 KB
Format:
OpenDocument Text
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: